Doxorubicin - NDC Database (Page 5)
85 records found
Page:
70710-1530 Sep 14, 2020
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Zydus Pharmaceuticals (Usa) Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Zydus Pharmaceuticals (Usa) Inc.
70710-1531 Sep 14, 2020
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Zydus Pharmaceuticals (Usa) Inc.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Zydus Pharmaceuticals (Usa) Inc.
70860-208 Oct 20, 2017
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
72603-103 May 29, 2019
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Northstar Rxllc
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Northstar Rxllc
72603-200 May 29, 2019
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Northstar Rxllc
Doxorubicin Hydrochloride 2 mg/ml Intravenous Injectable, Liposomal by Northstar Rxllc
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.